In line with genetic data, AML cell lines were resistant to ABCC1 inhibition by the pyrazolopyrimidine Reversan39 or the leukotriene D4 receptor antagonist MK-57140 (Supplementary Fig. 2A). The gene discussed is ABCC1; the disease is acute myeloid leukemia.